Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-09 Purchase |
2021-12-13 8:37 pm |
Aeglea BioTherapeutics Inc. | AGLE | Alspaugh Jonathan Chief Financial Officer |
50,000 | $3.72 | $186,000 | 90,372 (Direct) |
View |
| 2021-08-16 Purchase |
2021-08-18 5:21 pm |
Aeglea BioTherapeutics Inc. | AGLE | Alspaugh Jonathan Chief Financial Officer |
40,372 | $6.506 | $262,660 | 40,372 (Direct) |
View |
| 2020-04-30 Purchase |
2020-05-04 07:30 am |
Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO |
165,000 | $4.75 | $783,750 | 538,469 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-11-12 Option Award |
2021-11-16 4:34 pm |
N/A 2031-11-11 |
Aeglea BioTherapeutics Inc. | AGLE | Smith Hunter C Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:12 pm |
N/A 2031-07-05 |
Aeglea BioTherapeutics Inc. | AGLE | Alspaugh Jonathan Chief Financial Officer |
160,000 | $0 | 160,000 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:07 pm |
N/A 2031-06-17 |
Aeglea BioTherapeutics Inc. | AGLE | Souza Marcio Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 4:31 pm |
N/A 2031-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
40,000 | $0 | 40,000 (Indirect) |
View |
| 2021-06-08 Option Award |
2021-06-09 5:27 pm |
N/A 2031-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Shanafelt Armen Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 5:26 pm |
N/A 2031-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Mahatme Sandesh Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 5:25 pm |
N/A 2031-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Magovcevic-Liebisch Ivana Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 5:24 pm |
N/A 2031-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Lawton Alison Frances Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 5:23 pm |
N/A 2031-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | LAWLIS V BRYAN Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 5:23 pm |
N/A 2031-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Cox Russell J. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 7:31 pm |
N/A 2031-02-22 |
Aeglea BioTherapeutics Inc. | AGLE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
47,200 | $0 | 47,200 (Indirect) |
View |
Ownership |
2021-02-25 7:30 pm |
N/A N/A |
Aeglea BioTherapeutics Inc. | AGLE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
0 | $0 | 19,020,434 (Indirect) |
View |
| 2021-02-17 Option Award |
2021-02-19 5:09 pm |
N/A 2031-02-16 |
Aeglea BioTherapeutics Inc. | AGLE | Weber Steven VP, Controller&Princ Acctg Off |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 5:09 pm |
N/A 2031-02-16 |
Aeglea BioTherapeutics Inc. | AGLE | Sloan Leslie Chief Operating Officer |
160,000 | $0 | 160,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 5:08 pm |
N/A 2031-02-16 |
Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO |
330,000 | $0 | 330,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 5:07 pm |
N/A 2031-02-16 |
Aeglea BioTherapeutics Inc. | AGLE | Hanley Jr. Michael Conick Chief Commercial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
Ownership |
2021-02-08 7:51 pm |
N/A N/A |
Aeglea BioTherapeutics Inc. | AGLE | Weber Steven VP, Controller&Princ Acctg Off |
0 | $0 | 131,264 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:33 pm |
N/A 2030-12-14 |
Aeglea BioTherapeutics Inc. | AGLE | Lawton Alison Frances Director |
47,200 | $0 | 47,200 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-10 4:39 pm |
N/A 2030-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Shanafelt Armen Director |
28,100 | $0 | 28,100 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-10 4:28 pm |
N/A 2030-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Mahatme Sandesh Director |
28,100 | $0 | 28,100 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-10 4:26 pm |
N/A 2030-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Magovcevic Ivana Director |
28,100 | $0 | 28,100 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-10 4:24 pm |
N/A 2030-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | LAWLIS V BRYAN Director |
28,100 | $0 | 28,100 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-10 4:23 pm |
N/A 2030-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Cox Russell J. Director |
28,100 | $0 | 28,100 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-10 4:21 pm |
N/A 2030-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Bruhn Suzanne Louise Director |
28,100 | $0 | 28,100 (Direct) |
View |